Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Oncology
Filter     Order     Display # 
Date Item Title
22 Jul 2008 Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
22 Jul 2008 OncoVista Innovative Therapies to Begin Enrolling Patients in a Phase I/II Study of Cordycepin in Patients with Refractory TdT-Positive Leukemia
22 Jul 2008 Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
22 Jul 2008 Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
22 Jul 2008 Threshold Pharmaceuticals Presents Encouraging Interim Results From a Phase 1 Clinical Trial of TH-302 for Solid Tumors At AACR Conference On Translational Medicine
22 Jul 2008 BTG plc: Study Shows Abiraterone Can Successfully Treat Aggressive, Chemotherapy-Resistant Prostate Cancer
21 Jul 2008 Curis Selects Hsp90 Inhibitor CUDC-305 as Development Candidate from Targeted Cancer Drug Development Platform
21 Jul 2008 Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
21 Jul 2008 Ambrilia Initiates Phase I/II Clinical Program of its Novel Goserelin Formulation in Prostate Cancer
21 Jul 2008 Exelixis Initiates Phase 3 Trial of XL184 in Medullary Thyroid Cancer
21 Jul 2008 Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used in Successful Melanoma Trial
19 Jul 2008 The Multiple Myeloma Research Consortium (MMRC) Announces the Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal Antibody in Combination with Velcade
19 Jul 2008 BioNumerik Pharmaceuticals, Inc. Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
18 Jul 2008 Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial
17 Jul 2008 MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ (German Cancer Research Center)
17 Jul 2008 Bradmer Reports Progression Free Survial Data from Previous Phase II Glioblastoma Multiforme Trials
17 Jul 2008 ASA404 programme to expand with new pivotal trial in lung cancer
17 Jul 2008 EpiCept and GNI Partner to Develop Anti-Viral Hepatitis Drug in Asia
16 Jul 2008 Merck: Erbitux Approved for Use in Metastatic Colorectal Cancer in Japan
16 Jul 2008 Dendreon Initiates Phase 2 Trial of PROVENGE in Patients with Localized Prostate Cancer Prior to Surgery
16 Jul 2008 MOLOGEN AG: First patient enrolled in clinical study with cancer therapy MGN1703
15 Jul 2008 Infinity Provides Update On Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer
15 Jul 2008 OSI Pharmaceuticals Begins Clinical Development Program for OSI-027 in Patients with Advanced Solid Tumors or Lymphoma
14 Jul 2008 Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
14 Jul 2008 MRC Technology and Biolex Therapeutics Successfully Complete Collaboration to Humanize a Novel Antibody Targeting CD20
13 Jul 2008 Oxford BioMedica Announces Data Safety Monitoring Board Reccomendation for TroVax(R) Phase III Trist Study
13 Jul 2008 Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
10 Jul 2008 Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients with Relapsed Multiple Myeloma
10 Jul 2008 Calistoga Pharmaceuticals Initiates First Oncology Clinical Trial Of Novel PI3K Delta Inhibitor, CAL-101
10 Jul 2008 ValiRx Plc Acquires Global Rights to Novel Compound Targeted at Prostate Cancer
10 Jul 2008 Recruitment Completed in Ofatumumab CLL Front Line Study
10 Jul 2008 Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
10 Jul 2008 Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
09 Jul 2008 Polyphor successfully completes Phase I clinical trials of POL6326
09 Jul 2008 Merck Begins Erbitux Phase III Clinical Study in Gastric Cancer
08 Jul 2008 Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Daiichi Sankyo
07 Jul 2008 Early findings show promise as AS1411 AML study proceeds to higher-dose stage
07 Jul 2008 ImmunoGen, Inc. Announces Start of IMGN388 Clinical Testing
07 Jul 2008 Laboratorios Almirall, S.A. and Forest Laboratories, Inc. complete Phase III Studies in COPD
07 Jul 2008 Hana Biosciences Presents Alocrest and Menadione Data At the European Society for Medical Oncology Conference
03 Jul 2008 Phase III ARISER study with RENCAREX(R): patient recruitment successfully completed
02 Jul 2008 Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
01 Jul 2008 SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
01 Jul 2008 Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
01 Jul 2008 IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
30 Jun 2008 GlaxoSmithKline responds to FDA on Cervarix(R) and plans to submit final study data for approval
30 Jun 2008 Takeda Submitted a New Drug Application for Anti-Cancer Agent, panitumumab (recombinant)
30 Jun 2008 Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
30 Jun 2008 SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
29 Jun 2008 New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Vectibix(R) (Panitumumab)
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 251 - 300 of 2757

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics